Gene therapy and peripheral nerve repair: a perspective

Gene therapy and peripheral nerve repair: a perspective

Clinical phase I/II studies have demonstrated the safety of gene therapy for a variety of central nervous system disorders, including Canavan’s, Parkinson’s and Alzheimer’s disease, retinal diseases and pain. The majority of gene therapy studies in the CNS have used adeno-associated viral vectors (A...

Full description

Bibliographic Details
Main Authors: Stefan A. Hoyng, Fred eDe Winter, Martijn R. Tannemaat, Bas eBlits, Martijn J.A. Malessy, Joost eVerhaagen
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-07-01
Series:Frontiers in Molecular Neuroscience
Subjects:
Gene Therapy
Neurosurgery
Schwann cell
Lentiviral vector
Adeno-associated viral vector
Online Access:http://journal.frontiersin.org/Journal/10.3389/fnmol.2015.00032/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fnmol.2015.00032/full

Similar Items